Navire Pharmaa Subsidiary Of Bridgebio Pharmaand In Collaboration With The Institute For Applied Cancer Science At Md Andersonis Developing Inhibitors Of Shp2 As Targeted Therapeutics For The Treatment Of Multiple Cancersfounded In 2017 With The Aim Of Harnessing Advances In Understanding Of Shp2 Signaling To Create Novel Targeted Oncology Medicationsnavire Is Led By A Team Of Veteran Biotechnology Executivestogether With Patients And Physiciansthe Company Aims To Bring Safeeffective Treatments To Market As Quickly As Possible
No conferences found for this company.
| Company Name | Navire Pharma Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
